Zenas Biopharma, Common Etf Alpha and Beta Analysis
| ZBIO Etf | USD 11.29 0.71 5.92% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zenas BioPharma, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zenas BioPharma, over a specified time horizon. Remember, high Zenas BioPharma,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zenas BioPharma,'s market risk premium analysis include:
Beta 0.0545 | Alpha (0.64) | Risk 6.15 | Sharpe Ratio (0.12) | Expected Return (0.72) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Zenas |
Zenas BioPharma, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zenas BioPharma, market risk premium is the additional return an investor will receive from holding Zenas BioPharma, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zenas BioPharma,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zenas BioPharma,'s performance over market.| α | -0.64 | β | 0.05 |
Zenas BioPharma, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Zenas BioPharma,'s Buy-and-hold return. Our buy-and-hold chart shows how Zenas BioPharma, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Zenas BioPharma, Market Price Analysis
Market price analysis indicators help investors to evaluate how Zenas BioPharma, etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zenas BioPharma, shares will generate the highest return on investment. By understating and applying Zenas BioPharma, etf market price indicators, traders can identify Zenas BioPharma, position entry and exit signals to maximize returns.
Zenas BioPharma, Return and Market Media
The median price of Zenas BioPharma, for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 18.76 with a coefficient of variation of 15.13. The daily time series for the period is distributed with a sample standard deviation of 2.86, arithmetic mean of 18.91, and mean deviation of 2.08. The Etf received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Zenas BioPharma director acquires 999k in company stock | 09/17/2024 |
2 | Zenas started at buy by four banks on lead drug potential | 10/08/2024 |
3 | Acquisition by Moulder Leon O Jr of 7500 shares of Zenas BioPharma, at 15.0 subject to Rule 16b-3 | 11/18/2024 |
4 | Acquisition by Moulder Leon O Jr of 2500 shares of Zenas BioPharma, at 14.57 subject to Rule 16b-3 | 11/19/2024 |
About Zenas BioPharma, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zenas or other etfs. Alpha measures the amount that position in Zenas BioPharma, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zenas BioPharma, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zenas BioPharma,'s short interest history, or implied volatility extrapolated from Zenas BioPharma, options trading.
Build Portfolio with Zenas BioPharma,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Zenas Etf
Zenas BioPharma, financial ratios help investors to determine whether Zenas Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zenas with respect to the benefits of owning Zenas BioPharma, security.